Skip to main content
Etropal AD logo

Etropal AD — Investor Relations & Filings

Ticker · ETR ISIN · BG1100001038 LEI · 747800F04CMOK74FIJ68 BSOBGN Manufacturing
Open in API
Filings indexed 77 across all filing types
Latest filing 2026-03-26 Annual Report
Country BG Bulgaria
Listing BSOBGN ETR

About Etropal AD

https://www.etropal.eu/

Etropal AD is a manufacturer of disposable medical devices, primarily focused on providing life-sustaining care for patients with end-stage renal disease. The company's core activities include the research, development, and production of a comprehensive range of hemodialysis consumables, such as capillary dialyzers. In addition to its focus on dialysis solutions, the company is also active in the field of orthopedics and traumatology. This secondary business line involves the manufacturing of endoprostheses, implants, specialized bioceramic materials, and surgical instruments. With over thirty years of experience, Etropal AD offers a broad spectrum of products that meet high standards of safety and quality.

Recent filings

Filing Released Lang Actions
747800F04CMOK74FIJ68-20251231-BG-SEP.xhtml
Annual Report Classification · 95% confidence The document contains comprehensive financial statements, including a Consolidated Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows, and various financial ratios for the years 2025 and 2024. It also includes detailed notes on remuneration, related party transactions, and financial risk management. Given the depth of the financial data and the inclusion of management signatures, this document constitutes a formal annual financial report rather than a mere announcement or summary. FY 2025
2026-03-26 English
680446-годишни и шестмесечни справки на индивидуална основа.xlsx
Regulatory Filings
2026-03-26 Bulgarian
678861-Etropal_Q4_2025_Additional_information.pdf
Management Reports Classification · 95% confidence The document is titled 'Additional Information to the Interim Financial Report' for Etropal AD as of 31.12.2025. It provides management commentary, shareholder data, and disclosures required by Bulgarian regulatory ordinance No. 2. While it references an interim financial report, it functions as the management's discussion and analysis (MDA) component of the quarterly reporting package, detailing business trends, organizational changes, and legal status. It is not a standalone financial statement, but rather the management report accompanying the interim financial results. FY 2025
2026-03-01 Bulgarian
678860-Etropal_Q4_2025_Internal_information.pdf
Regulatory Filings Classification · 95% confidence The document is a short notification (under 5,000 characters) from Etropal AD regarding the disclosure of 'inside information' (вътрешна информация) pursuant to Article 7 of the EU Market Abuse Regulation. It directs the reader to an external financial media link (x3news.com) to access the actual information. Following the 'Menu vs Meal' rule, this is an announcement of information rather than the report itself, and as it is a general regulatory disclosure, it falls under the RNS category.
2026-03-01 Bulgarian
678864-Etropal_Q4_2025_Prilojenie_4.pdf
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure filed in accordance with Bulgarian Ordinance No. 2 regarding the disclosure of information for public companies. It provides specific updates on corporate events such as changes in control, insolvency proceedings, material transactions, and legal matters. Since it does not fit into specific categories like financial reports or dividend announcements, and serves as a general regulatory disclosure required by law, it is classified as a Regulatory Filing (RNS).
2026-03-01 Bulgarian
678862-Management report Q4_2025cons.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive interim consolidated report for the fourth quarter of 2025 for 'Etropal' AD. It contains detailed financial statements, including balance sheet data, income statements, and management analysis of business trends, risks, and operational performance. It is not an announcement of a report (RPA) nor a simple regulatory filing (RNS), but a substantive quarterly financial report. Q4 2025
2026-03-01 Bulgarian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.